Stammdaten
Unternehmen
| Name | Evolus, Inc. |
|---|---|
| Ticker | EOLS |
| CIK | 0001570562 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Evolus, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:37:34.260504 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-20 | Avelar Rui | Officer, See Remarks | Open Market Sale | -3,119 | 4.75 | -14,815.25 | -10,8% | |
| 2026-03-20 | Avelar Rui | Officer, See Remarks | Open Market Sale | -3,119 | 4.75 | -14,815.25 | -10,8% | |
| 2026-03-20 | MOATAZEDI DAVID | Director, Officer, See Remarks | Open Market Sale | -13,669 | 4.75 | -64,929.12 | -47,4% | |
| 2026-03-17 | Avelar Rui | Officer, See Remarks | Open Market Sale | -29,996 | 4.89 | -146,629.45 | -107,0% | |
| 2026-03-17 | Avelar Rui | Officer, See Remarks | Open Market Sale | -29,996 | 4.89 | -146,629.45 | -107,0% | |
| 2025-12-22 | Avelar Rui | Officer, See Remarks | Open Market Sale | -2,261 | 7.15 | -16,167.73 | -11,8% | |
| 2025-12-22 | MOATAZEDI DAVID | Director, Officer, See Remarks | Open Market Sale | -10,539 | 7.15 | -75,361.23 | -55,0% | |
| 2025-12-22 | Avelar Rui | Officer, See Remarks | Open Market Sale | -2,261 | 7.15 | -16,167.73 | -11,8% | |
| 2025-12-22 | Avelar Rui | Officer, See Remarks | Open Market Sale | -2,261 | 7.15 | -16,167.73 | -11,8% | |
| 2025-08-22 | Yamagishi-Dressler Tomoko | Officer, Chief Marketing Officer | Open Market Sale | -5,722 | 7.51 | -42,972.22 | -31,4% | |
| 2025-08-15 | Stewart Brady | Director | Open Market Purchase | 30,000 | 6.82 | 204,486.00 | +149,2% | |
| 2025-06-16 | MOATAZEDI DAVID | Director, Officer, See Remarks | Open Market Sale | -16,582 | 9.89 | -164,054.02 | -119,7% | |
| 2025-06-13 | MOATAZEDI DAVID | Director, Officer, See Remarks | Open Market Sale | -111,323 | 10.05 | -1,119,141.25 | -816,5% | |
| 2025-06-09 | White Albert G III | Director | Open Market Purchase | 20,000 | 9.45 | 189,000.00 | +137,9% | |
| 2025-06-09 | White Albert G III | Director | Open Market Purchase | 20,000 | 9.45 | 189,000.00 | +137,9% | |
| 2025-05-13 | Beaver Sandra | Officer, Chief Financial Officer | Open Market Sale | -6,494 | 10.02 | -65,069.88 | -47,5% | |
| 2025-05-12 | Avelar Rui | Officer, See Remarks | Open Market Sale | -3,385 | 9.87 | -33,396.75 | -24,4% | |
| 2025-05-12 | Avelar Rui | Officer, See Remarks | Open Market Sale | -3,385 | 9.87 | -33,396.75 | -24,4% | |
| 2025-05-12 | MOATAZEDI DAVID | Director, Officer, See Remarks | Open Market Sale | -15,787 | 9.87 | -155,756.12 | -113,6% | |
| 2025-05-12 | Avelar Rui | Officer, See Remarks | Open Market Sale | -3,385 | 9.87 | -33,396.75 | -24,4% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.